Zahra Kashi

ORCID: 0000-0002-4683-1323
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Thyroid Disorders and Treatments
  • Thyroid Cancer Diagnosis and Treatment
  • Diabetes and associated disorders
  • Growth Hormone and Insulin-like Growth Factors
  • T-cell and B-cell Immunology
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Pituitary Gland Disorders and Treatments
  • Vitamin D Research Studies
  • Diabetes Management and Education
  • Blood groups and transfusion
  • Immune Cell Function and Interaction
  • Gestational Diabetes Research and Management
  • Sexual function and dysfunction studies
  • Metabolism, Diabetes, and Cancer
  • Renal Transplantation Outcomes and Treatments
  • Liver Disease Diagnosis and Treatment
  • Advanced biosensing and bioanalysis techniques
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Rheumatoid Arthritis Research and Therapies
  • COVID-19 Clinical Research Studies
  • RNA Interference and Gene Delivery
  • Diabetic Foot Ulcer Assessment and Management
  • Apelin-related biomedical research
  • Immunodeficiency and Autoimmune Disorders
  • Natural Antidiabetic Agents Studies

Mazandaran University of Medical Sciences
2016-2025

Imam Khomeini Hospital
2007-2023

Semnan University of Medical Sciences
2021

Universal Scientific Education and Research Network
2021

University of Veterinary and Animal Sciences
2020

Iran University of Medical Sciences
2018

Diabetes Research Center
2016-2018

Ferdowsi University of Mashhad
2017

Babol University of Medical Sciences
2011

ZRT Laboratory
2005

Insulin resistance (IR) is a critical component of metabolic syndrome, primarily linked to obesity. It contributes impaired glucose metabolism, beta-cell dysfunction, and the onset type 2 diabetes. This study aimed develop DNAsome nanocarrier designed for targeted delivery small interfering RNA (siRNA) inhibit mRNA Transforming growth factor beta-like Stimulated Clone 22 D4 (TSC22D4), thereby enhancing insulin sensitivity in hepatocytes. The was constructed using Y-DNA building blocks...

10.22038/ijbms.2024.81998.17744 article EN PubMed 2025-01-01

We aimed to evaluate the effects of a hydroalcoholic extract Juglans regia L. leaves on blood glucose level and cardiovascular risk factors in type 2 diabetic patients. In this randomized, double-blind, placebo-controlled, parallel-group (2 arms) clinical trial, 50 patients were divided into two groups: treatment group (receive capsules containing 100 mg J. leaf extract) control placebo, microcrystallin cellulose). Baseline participant data matched between arms study. administered prepared...

10.1186/s12906-018-2268-8 article EN cc-by BMC Complementary and Alternative Medicine 2018-07-04

Background In this study, we investigated whether response to metformin, the most frequently drug for diabetes treatment, influences therapeutic effects of antilipidemic medication in newly diagnosed patients with type 2 mellitus (T2DM). Methods A total 150 T2DM were classified into two groups following 3 months metformin therapy (1000 mg twice daily): responders (patients showing ≥1% reduction HbA1c from baseline) and nonresponders <1% baseline). The received atorvastatin 20 mg, gemfibrozil...

10.1371/journal.pone.0151543 article EN cc-by PLoS ONE 2016-03-15

Background: Cabergoline is a long-acting agonist of dopamine, which has high affinity to dopamine receptors (type 2). Treatment using dopaminergic reduces hypothalamic stimulation that increases during liver gluconeogenesis, lipids synthesis, and insulin resistance. Our aim was evaluate the effects cabergoline on blood glucose levels in patients with type 2 diabetes mellitus (DM). Methods: This study double-blind, controlled clinical trial DM. The received treatments placebo (control group;...

10.1097/md.0000000000004818 article EN cc-by-nc Medicine 2016-10-01

Impaired fasting glucose (IFG), and impaired tolerance (IGT) are two prediabetes conditions which have some correlation with macrovascular disorders. The risk of microvascular complications in these groups is not clear.The prevalence albuminuria subjects IFG IGT was evaluated the present study.In this study three were entered (45 each group): IFG, IGT, normal as control. urine albumin-creatinine ratio studied morning spot samples to detect microalbuminuria. followed up for years, blood sugar...

10.5812/numonthly.7646 article EN cc-by-nc Nephro-Urology Monthly 2013-03-30

Diabetes mellitus (DM) is a chronic disease inducing short-term and long-term complications including sexual dysfunction (SD) which can consequently reduce patients' quality of life. Given the limited literature on frequency SD in men experiencing diabetes northern Iran, present study was conducted city Sari Mazandaran Province, with aim investigating type II diabetes.Using descriptive cross-sectional research design, total number 350 male patients suffering from referring to endocrinology...

10.22088/cjim.11.3.295 article EN DOAJ (DOAJ: Directory of Open Access Journals) 2020-05-01

Some studies have shown largest thyroid nodule size, especially ≥4cm that can predict malignancy and reduce fine needle aspiration biopsy (FNAB) accuracy. Therefore, this study is designed to evaluate relationship between sizes with its effect on FNBA accuracy.a retrospective analytical design aims investigate all patients nodules who referred surgery department of Imam-Khomeini Hospital Mazandaran University Medical Sciences in Sari from 20 March 2008 22 2014. We collected patient's...

10.5455/aim.2016.24.347-350 article EN Acta Informatica Medica 2016-01-01

Diabetic nephropathy is the most important cause of end stage renal disease (ESRD). Aldosterone involved in damage through induction fibrosis, inflammation and necrosis kidney tissue. Previous studies have demonstrated that combination angiotensin receptor blocker (ARB) spironolactone (an anti-aldosterone drug) are efficient for albuminuria reduction.This study was designed to evaluate effect alone on diabetic nephropathy.In this double blind randomized clinical trial, 60 type II patients...

10.5812/numonthly.12148 article EN cc-by-nc Nephro-Urology Monthly 2014-01-14

&lt;p&gt;&lt;strong&gt;BACKGROUND:&lt;/strong&gt; Untreated maternal hypothyroidism can have adverse effects on both the mother and fetus, but it potentially be prevented by adequate levothyroxine replacement. This study was conducted to determine what percentage of hypothyroid pregnant women who were taking needed adjust their medication dosage, when how much should increased.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;METHODS&lt;/strong&gt;&lt;strong&gt;:&lt;/strong&gt; In this longitudinal study, 81...

10.5539/gjhs.v8n4p227 article EN cc-by Global Journal of Health Science 2015-09-01
Coming Soon ...